How To Write Covered Calls - An Ongoing Real Case Study! Message Board

STOCKTALK

We've detected that you're using an ad content blocking browser plug-in or feature. Ads provide a critical source of revenue to the continued operation of Silicon Investor. We ask that you disable ad blocking while on Silicon Investor in the best interests of our community. If you are not using an ad blocker but are still receiving this message, make sure your browser's tracking protection is set to the 'standard' level.

Strategies & Market Trends : How To Write Covered Calls - An Ongoing Real Case Study!

Public Reply Prvt Reply Mark as Last Read File

Previous 10 Next 10 Previous Next

To: tuck who wrote (9534)	1/28/1999 9:28:00 AM
From: Casaubon	Read Replies (2) of 14162

yes, you are quite correct on all aspects of your analysis! VRTX has lots of cash to play the game. The management is doing a bang up job controlling costs. They operate the budget slightly in the red to pay for all those clinical trials. The main revenue sources have been excellent collaborations with respected companies as well as rich public offerings during very generous periods in the market. On top of a strong money game is the science. This company has an amazing patent portfolio, in some real big money disease areas. This isn't licenced material, either. Like I said, Vertex has a very strong research staff. I will take your advice and buy some protective puts if the FDA announces approval and the volume/stock jumps up in price! Thank you all so much for the excellent info. PS what do you think of OTEXF and PRXL

Report TOU Violation

Share This Post

Public Reply Prvt Reply Mark as Last Read File

Previous 10 Next 10 Previous Next